Cystic lesions in the liver are common and usually benign in patients where there are no hepatic malignant risk factors, no history of malignancy, no exposure to hydatids and no cirrhosis. [5] They ...
Liver complications are frequent and serious causes of morbidity and mortality in patients who undergo haematopoietic SCT (HSCT) following myeloablative conditioning. A variety of etiological factors ...
Liver lesions are groups of abnormal cells in your liver. Your doctor may call them a mass, cyst, or tumor. Noncancerous, or benign, liver lesions are common and can be found in up to 30% of people ...
Semin Liver Dis. 2013;33(3):236-247. Focal nodular hyperplasia has no malignant potential and usually remains stable or decreases in size over time. Less than 20% of patients with FNH develop symptoms ...
Focal nodular hyperplasia (FNH) is a benign hepatic tumor most commonly detected incidentally during imaging. Typically affecting women of reproductive age, FNH is characterized by a ...
Association of interleukin-6 levels and neutropenia during gemcitabine monotherapy for advanced pancreatic cancer. Background: Oxaliplatin is recognized to induce vascular lesions in the nontumoral ...
WAYNE, N.J., July 8 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc., a leader in diagnostic imaging, announced today that the U.S. Food and Drug Administration (FDA) has approved EOVIST(R) ...
Please provide your email address to receive an email when new articles are posted on . For lesions of unknown etiology, the ACG recommends multiphasic contrast-enhanced imaging. The ACG recommends ...
Liver lesions are abnormal growths on your liver. Most are noncancerous, or benign. Benign liver lesions don’t cause symptoms or require treatment unless they grow very large. Liver lesions are found ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results